cannabis & hemp regulatory news around cannabinoid category:

CBN

FDA Human Foods Program 2025: Reading the Guidance Agenda for CBD in Foods and Supplements

The FDA Human Foods Program 2025 guidance agenda signals tighter post-market scrutiny on CBD, CBN, and CBG and expanded adverse event reporting integration.

Guide

Oregon’s 2025 CBN Clampdown: GRAS/NDIN or Goodbye for Artificially Derived Cannabinoids

Oregon OLCC bulletin CE2025-05 requires artificially derived CBN products to meet federal GRAS or NDIN standards by July 1, 2025, or leave shelves.

Analysis

Beyond Delta-8: Tracking the Fate of Minor Cannabinoids Under New U.S. Laws

U.S. authorities are closing loopholes on minor cannabinoids including delta-8 THC, THCA, HHC, CBN, THCP, and delta-10 under new 2025 hemp laws.